Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) faced a turbulent week as its shares plunged 17%, despite announcing encouraging results from a Phase 3 trial of itepekimab for chronic obstructive ...

Guardant Health, Inc. (NASDAQ:GH) and research collaborators have unveiled results from the largest study to date on circulating tumor DNA (ctDNA) testing in stage III colon cancer, presented at ...

These 4,000+ transactions weren’t blockchain interactions in a lab or DeFi trades between wallets. They were in-person, point-of-sale (POS) payments made over the course of a single day at one ...

Kymera Therapeutics, Inc. (NASDAQ:KYMR) is set to unveil results from its Phase 1 clinical trial of KT-621, a first-in-class oral STAT6 degrader, on Monday, June 2, 2025. The announcement will be ...

On May 29, Piper Sandler raised its price target on Pure Storage, Inc. (NYSE:PSTG) from $53 to $66 and kept an Overweight rating on the stock. James Fish from Piper Sandler made the price target ...

We recently published a list of Small Stocks, But Explosive: These 10 Firms Crushed The Market Last Week. In this article, we are going to take a look at where Spero Therapeutics, Inc. (NASDAQ ...

We recently published a list of These 10 Stocks Lost This Much Today. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other ...

Officially completing its acquisition of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT), Sun Pharmaceutical Industries Ltd. has expanded its immuno-oncology footprint. The deal, announced earlier ...

For instance, a technique for detecting a chemical can find application in a pharmaceutical lab (e.g., to detect active pharmaceutical ingredients) or in regulation (e.g., to detect contamination ...

We recently published a list of While Wall Street Naps, These 10 Stocks Run Wild. In this article, we are going to take a look at where Roivant Sciences Ltd. (NASDAQ:ROIV) stands against other ...

Beam Therapeutics Inc. (NASDAQ:BEAM) has secured U.S. FDA orphan drug designation for BEAM-302, its pioneering genetic medicine targeting alpha-1 antitrypsin deficiency (AATD), a rare inherited ...

Candel Therapeutics, Inc. (NASDAQ:CADL) has secured FDA Regenerative Medicine Advanced Therapy (RMAT) designation for its lead immunotherapy candidate, CAN-2409 (aglatimagene besadenovec ...